Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-03-07
1998-08-04
Jordan, Charles T.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514357, 546304, 546330, A01N 4340, C07D21172
Patent
active
057894272
ABSTRACT:
The present invention concerns compounds and their use to inhibit the activity of a receptor tyrosine kinase. The invention is preferably used to treat cell proliferative disorders such as cancers characterized by over-activity or inappropriate activity HER2 or EGFR.
REFERENCES:
patent: 3313771 (1967-04-01), Dressler et al.
patent: 5217999 (1993-06-01), Levitzki et al.
patent: 5302606 (1994-04-01), Spada et al.
T. Lotta, J. Taskinen, R. Backstrom, E. Nissinen, Journal of Computer-Aided Molecular Design, 1992, vol. 6, pp. 253-272, Mar. 1992.
Aaronson, S., "Growth Factors and Cancer," Science 254:1146-1153 (1991).
Affleck et al., Proc. Annun. Meeting American Associate Cancer Research 34:A2298 (1993).
Anafi et al., "Selective Interactions of Transforming and Normal abI Proteins with ATP, Tyrosine-Copolymer Substrates, and Tyrphostins," J. Bio. Chem. 267:4518-4523 (1992).
Andrews et al. (American Veterinary Medicine Association Panel on Euthanasia), "1993 Report of the AVMA Panel on Authanasia," J. American Veterinary Medicine Association 202(2):229-249 (1993).
Baselga et al., "Antitumor Effects of Doxorubicin in Combination With Anti-epidermal Growth Factor Receptor Monoclonal Antibodies," J. of Natl. Cancer Institute 85(16):1327-1333 (1993).
Bilder et al., "Tyrphostins inhibit PDGF-induced DNA synthesis and associated early events in smooth muscle cells," Am. J. Physiol. 260 (Cell Physiol.29):C721-C730 (1991).
Birchall et al., "Compositions for Killing internal parasites containing 3-teri-alkyl-4-hydroxy-5-halobenzylidene-malononitriles," Chemical Abstracts 88:535 (1978).
Bryckaert et al., "Inhibition of Platelet-Derived Growth Factor-Induced Mitogenesis and Tyrosine Kinase Activity in Cultured Bone Marrow Fibroblasts by Tyrphostins," Exp. Cell Research 199:255-261 (1992).
Caraglia et al., "Cytosine arabinoside increases the binding of .sup.125 I-labelled epidermal growth factor and .sup.125 I-transferrin and enhances the in vitro targeting of human tumour cells with anit-(growth factor receptor)mAb," Cancer Immunol. Immunother. 37:150-156 (1993).
Carboni et al., "Cyanocarbon Chemistry. XI. Malononitrile Dimer," J. Am. Chem. Soc. 80:2838-2840 (1958).
Carraway and Cantley, "A Neu Acquaintance for ErbB3 and ErbB4; A Role for Receptor Hereodimerization in Growth Signaling," Cell 78:5-8 (1994).
Carraway et al., "The erbB3 Gene Product Is A Receptor for Heregulin," J. Biol. Chem. 269:14303-14306 (1994).
Dati et al., "Inhibition of c-erbB-2 oncogene expression by estrogens in human breast cancer cells," Oncogene 5:1001-1006 (1990).
Decker and Lohmann-Matthes, "A quick and simple method for the quantitation of lactate dehydrogenase release in measurements of cellular cytotoxicity and tumor necrosis factor (TNF) activity," J. Immunol. Methods 15:61-69 (1988).
Dougall et al., "The neu-oncogene: signal transduction pathways, transformation mechanisms envolving employees" Oncogene 9:2109-2123 (1994).
Ferris et al., "Synthesis of Zuinazoline Nucleosides from Ribose and Anthranilonitrile. Application of Phase-Transfer Catalysis in Nucleoside Synthesis," J. Org. Chem. 44(2):173-178 (1979).
Floege et al., "Factors involved in the regulation of mesangial cell proliferation in vitro and in vivo," Kidney International 43S:47-54 (1993).
Gazit et al., "Tyrphostins. 1. Synthesis and Biological Activity of Protein Tyrosine Kinase Inhibitors," J. Med. Chem. 32:2344-2352 (1989).
Gazit et al., "Tyrphostins. 2. Heterocyclic and .alpha.-Substituted Benzylidenemalononitrile Tyrphostins as Potent Inhibitors of EGF Receptor and ErbB2
eu Tyrosine Kinases," J.Med.Chem. 34:1896-1907 (1991).
Gazit et al., "Tyrphostins. 3. Structure-Activity Relationship Studies of a .alpha.-Substituted Benzylidenemalononitrile 5-S-Aryltyrphostins" J.Med.Chem. 36:3556-3564 (1993).
Gottardis et al., "Estradiol-Stimulated Growth of MCF-7 Tumors Implanted in Athymic Mice: A Model to Study the Tumoristatic Action of Tamoxifen," J. Steriod Biochem. 30(1-6):331-314 (1988).
Hale et al., "Prognostic value of epidermal growth factor receptor expression in cervical carcinoma," J. Clin. Pathol. 46: 149-153 (1993).
Harris et al., "Breast Cancer (First of Three Parts)," New England J. of Medicine 327(5):319-328 (1992).
Hoekstra et al., "Differential effects of steurosporine and tyrphostins on receptor tyrosine kinase autophosphorylation and peptide substrate phosphorylation," Experimental Therapeutics from 84th Annual Meeting of American Association for Cancer Research, vol. 34, #2455 (1993).
Honegger et al., "Point Mutation at the ATP Binding Site of EGF Receptor Abolishes Protein-Tyrosine Kinase Activity and Alters Cellular Routing," Cell 5:199-209 (1987).
Hudziak et al., "p185.sup.HER2 Monoclonal Antibody Has Antiproliferative Effects In Vitro and Sensitizes Human Breast Tumor Cells to Tumor Necrosis Factor," Molecular and Cellular Biology 9:1165-1172 (1989).
Issidorides and Haddadin, "Benzofurazan Oxide. II. Reactions with Enolate Anions," J. Org. Chem. 31:4067-4068 (1966).
Karameris et al., "Expression of Epidermal Growth Factor (EGF) and Epidermal Growth Factor Receptor (EGFR) in Gastric and Colorectal Carcinomas, An Immunohistological Study of 63 Cases," Path. Res. Pract. 189:133-137 (1993).
Koenders et al., "Epidermal growth factor receptor and prognosis in human breast cancer: a prospective study," Breast Cancer Research and Treatment 25:21-27 (1993).
Korzeniewski and Callewaert, "An Enzyme-Release Assay for Natural Cytotoxicity.sup.1," J. Immunol. Methods 64:313 (1983). N-Oxides," J.Org. Chem. 40(24):3608-3610 (1975).
Levitzki, A., "Tyrphostins--Potential Antiproliferative Agents and Novel Molecular Tools," Biochem. Pharm. 40(5):913-918 (1990).
Ley and Seng, "Synthesen unter Verwendung von Benzofuroxan," Synthesis 1975:415-422 (1975).
Lyall et al., "Tyrphostins Inhibit Epidermal Growth Factor (EGF)-Receptor Tyrosine Kinase Activity in Living Cells and EGF-stimulated Cell Proliferation," J. Bio. Chem. 264:14503-14509 (1989).
Marshall, E., "Search for a Killer: Focus Shifts from Fat to Hormones," Science 259:618-621 (1993).
Mosmann, "Rapid Colorimetric Assay for Cellular Growth and Survival: Application to Proliferation and Cytotoxicity Assays," J. Immunol. Methods 65:55-63 (1983).
Mitus and Rosenthal, "Ch. 30-Adult Leukemias," Textbook of Clinical Oncology , Holleb, Fink and Murphy eds., pp. 410-432.
Ohmichi et al.m "The Tyrosine Kinase Inhibitor Tyrphostin Blocks the Cellular Actions of Nerve Growth Factor," Biochemistry 32:4650-4658 (1993).
Osborne et al., "Effect of Estrogens and Antiestrogens on Growth of Human Breast Cancer Cells in Athymic Nude Mice," Cancer Research 45:584-590 (1985).
Osherov et al., "Selective Inhibition of the EGF and Neu receptors by Tyrophostins," J. Cell Biochem. S17A:237 (1993).
Osherov et al., "Selective Inhibition of the Epidermal Growth Factor and HER2/Neu Receptors by Tyrphostins, " J. Bio. Chem. 268:11134-11142 (1993).
Ozzello and Sordat, "Behavior of Tumors Produced by Transplantation of Human Mammary Cell Lines in Athymic Nude Mice," Eur. J. Cancer 16:553-559 (1980).
Pawson and Schlessinger, "SH2 and SH3 domains," Current Biology 3(7):434-441 (1993).
Peterson and Barnes, "Genistein and Biochanin A Inhibit the Growth of Human Prostate Cancer Cells but not Epidermal Growth Factor Receptor Tyrosine Autophosphorylation," The Prostate 22:335-345 (1993).
Pigott et al., "Expression of epidermal growth factor receptor in human glioblastoma multiforme," Brit. J. of Neurosurgery 7:261-265 (1993).
Plowman et al., "Heregulin induces tyrosine phosphorylation of HER4/p180.sup.erbB4," Nature 366:473-475 (1993).
Pui and Rivera, "Ch. 31-Childhood Leukemias," Textbook of Clinical Oncology , Holleb, Fink and Murphy eds., pp. 433-452.
Reddy et al., "Inhibition of Breast Cancer Cell Growth in Vitro by a Tyrosine Kinase Inhibitor," Cancer Research 52:3636-3641 (1992).
Rendu et al., "Inhibition of Breast Cancer Cell Growth in Vitro by a Tyrosine Kinase Inhibitor," Biochem. Pharm. 44(5):881-888 (1992).
Rusch et al., "Differential Expression of the Epidermal Growth Factor Receptor and Its Lgands in Primary Non-Small Ce
Chen Hui
Gazit Aviv
Hirth Klaus Peter
Mann Elaina
Shawver Laura K.
Hardee John R.
Jordan Charles T.
Sugen Inc.
Yissum Research & Development Company of the Hebrew University o
LandOfFree
Methods and compositions for inhibiting cell proliferative disor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods and compositions for inhibiting cell proliferative disor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and compositions for inhibiting cell proliferative disor will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1177555